Simulations of the HIV epidemic in sub-Saharan Africa: Sexual transmission versus transmission through unsafe medical injections

Sexually Transmitted Diseases

Volumn 33, Issue 3, 2006, Pages 127-134

  French, Katherine ^a   Riley, Steven ^b   Garnett, Geoff ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IATROGENIC DISEASE; INFECTION; INFECTION PREVENTION; INJECTION; MALE; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SEXUALITY; SIMULATION; AFRICA SOUTH OF THE SAHARA; AGED; BIOLOGICAL MODEL; CHILD; COMPARATIVE STUDY; EPIDEMIC; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE; SEXUAL BEHAVIOR; VIROLOGY;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IATROGENIC DISEASE; INFANT; INFANT, NEWBORN; INJECTIONS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREVALENCE; SEXUAL BEHAVIOR;

EID: 33645968687     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000204505.78077.e5     Document Type: Article

References (21)

1. Gisselquist DP. Estimating HIV-1 transmission efficiency through unsafe medical injections. Int J STD AIDS 2002; 13:152-159.
2. Gisselquist D, Rothenberg R, Potterat J, et al. HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. Int J STD AIDS 2002; 13:657-666.
3. Schmid GP, Buve A, Mugyenyi P, et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004; 363:482-488.
4. Kiwanuka N, Gray RH, Serwadda D, et al. The incidence of HIV-1 associated with injections and transfusions in a prospective cohort, Rakai, Uganda. AIDS 2004; 18:342-344.
5. Gisselquist D, Potterat JJ. Confound it: Latent lessons from the Mwanza trial of STD treatment to reduce HIV transmission. Int J STD AIDS 2003; 14:179-184.
6. Van de Perre P, Carael M, Nzaramba D, et al. Risk factors for HIV seropositivity in selected urban-based Rwandese adults. AIDS 1987; 1:207-211.
7. Zaba BW, Carpenter LM, Boerma JT, et al. Adjusting ante-natal clinic data for improved estimates of HIV prevalence among women in sub-Saharan Africa. AIDS 2000; 14:2741-2750.
8. Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: Literature review and regional estimates. BMJ 2003; 327:1075.
9. Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15:7-16.
10. Auvert B, Ballard R, Campbell C, et al. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS 2001; 15:885-898.
11. N'Galy B, Ryder RW, Bila K, et al. Human immunodeficiency virus infection among employees in an African hospital. N Engl J Med 1988; 319:1123-1127.
12. Lopman BA, Garnett GP, Mason PR, et al. Individual level injection history: A lack of association with HIV incidence in rural Zimbabwe. Public Library of Science: Medicine 2005; 2:e37.
13. Bulterys M, Chao A, Habimana P, et al. Incident HIV-1 infection in a cohort of young women in Butare, Rwanda. AIDS 1994; 8:1585-1591.
14. UNAIDS Reference Group on Estimates Modelling and Projections. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS 2002; 16:W1-14.
15. Garnett GP, Gregson S. Monitoring the course of the HIV-1 epidemic: The influence of patterns of fertility on HIV-1 prevalence estimates. Mathematical Population Studies 2000; 8:251-277.
16. Abdala N, Gleghorn AA, Carney JM, et al. Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. J Acquir Immun Defic Syndr 2001; 28:487-494.
17. Baggaley R, Boily M-C, White R, et al. Systematic review of HIV-1 transmission probabilities in absence of antiretroviral therapy. In: UNAIDS Reference Group on Estimates Modelling and Projection. Geneva, 2004.
18. Kane A, Lloyd J, Zaffran M, et al. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: Model-based regional estimates. Bull World Health Organ 1999; 77:801-807.
19. Garnett GP, Anderson RM. Factors controlling the spread of HIV in heterosexual communities in developing countries: Patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci 1993; 342:137-159.
20. UNAIDS. 2004 Report on the Global HIV/AIDS Epidemic: 4th Global Report, 2004.
21. Simonsen L, Kane A, Lloyd J, et al. Unsafe injections in the developing world and transmission of bloodborne pathogens: A review. Bull World Health Organ 1999; 77:789-800.